Paediatricians flag a surge in paediatric inflammatory multisystem syndrome following COVID-19 infection, with more than 6,000 cases reported in the US and 35 in Australia. PIMS-TS is most common in children around the age of 9, weeks after they’ve experienced a mild or asymptomatic case of COVID-19. Currently, doctors have not been able to identify an exact causal effect, but some scientists believe a child’s body can have a delayed reaction to the virus.
“We are getting much better now at recognising the syndrome and treating it” explains Associate Professor Nigel Crawford.
While this complication is very rare, scientists are currently uncertain whether the highly infectious Omicron variant will perpetuate a spike in PIMS-TS occurrences.
Follow the link below to read the full article:
Children with COVID-19 are at risk of a rare complication. Will Omicron make MIS-C more common?